🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    Single Technologies

    Single Technologies develops Theta, a 3-D Sequencing platform that utilizes a multi-layered cube structure to increase the number of DNA sequences read in parallel. The technology enables high-throughput DNA analysis for both in situ and solution-based sequencing, specifically targeting applications in genomics, proteomics, and spatial biology. The system allows researchers to sequence directly within cells to gain higher read counts and analyze more cells per run.

    Visit websiteStockholm, SwedenFounded 2012
    Healthtech
    Biotechnology
    Genomics
    Life Sciences

    Funding summary

    Total raised
    €18.8M
    Funding rounds
    3

    Investors in Single Technologies

    Investors on record for Single Technologies. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like Single Technologies?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy